跳至主要内容
临床试验/ISRCTN50008265
ISRCTN50008265进行中(未招募)未知

Consequences of reducing hypoglycemia-inducing glucose-lowering medication in people with type two diabetes: an open cluster controlled intervention study comparing the implementation of a deprescribing program in primary care practises versus usual care

Amsterdam University Medical Centers0 个研究点目标入组 404 人开始时间: 2023年3月9日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
404

研究概览

简要总结

2024 Protocol article in https://pubmed.ncbi.nlm.nih.gov/39049109/ (added 29/07/2024)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age 70 years or older
  • 2. Having type 2 diabetes
  • 3. Using insulin or sulfonyl urea derivative drugs
  • 4. Recent Hba1c below 54 mmol/ mol or if deemed fragile by the GP practice below 58mmol/mol

排除标准

  • Previously having indicated to be not willing to participate in studies using routine care electronic data

研究者

发起方
Amsterdam University Medical Centers

相似试验